form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________

FORM 8-K
 
CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
October 28, 2008
Date of Report (Date of earliest event reported)

APPLIED BIOSYSTEMS INC.
(Exact Name of Registrant as Specified in Charter)

Delaware
001-04389
06-1534213
(State or other jurisdiction of incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)

   
301 Merritt 7
Norwalk, Connecticut
 
06851
(Address of principal executive offices)
(Zip Code)
(203) 840-2000
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
 
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
 
 
 
Item 8.01.      Other Events.

On October 28, 2008, Applied Biosystems Inc. (the “Company”) issued a press release, a copy of which is attached hereto as Exhibit 99 and incorporated herein by reference, announcing that the Company’s stockholders voted to approve the Company’s proposed merger with Invitrogen Corporation at the special meeting of stockholders held on that date.

Item 9.01.      Financial Statement and Exhibits.

(d)      Exhibits.
 
The following exhibits are filed with this Report:

            Exhibit No.
  
Description
99
  
Press Release, dated October 28, 2008, issued by Applied Biosystems Inc.
     
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
APPLIED BIOSYSTEMS INC.
     
     
     
 
By:
/s/ Thomas P. Livingston
 
   
Thomas P. Livingston
   
Vice President and Secretary
Date: October 29, 2008
 
 
EXHIBIT INDEX


       Exhibit No.
  
Description
99
  
Press Release, dated October 28, 2008, issued by Applied Biosystems Inc.